Crosstalk between viruses and PML nuclear bodies: A network-based approach

Frontiers in Bioscience

Volumn 16, Issue 7, 2011, Pages 2910-2920

  Van Damme, Ellen ^a   Van Ostade, Xaveer ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

ND10; PML NB; Promyelocytic Leukemia protein; Review; Virus infection

Indexed keywords

NUCLEIC ACID; TUMOR PROTEIN; VIRUS PROTEIN;

BIOLOGICAL MODEL; CELL NUCLEUS INCLUSION BODY; HUMAN; METABOLISM; PROMYELOCYTIC LEUKEMIA; REVIEW; VIROLOGY; VIRUS INCLUSION;

HUMANS; INCLUSION BODIES, VIRAL; INTRANUCLEAR INCLUSION BODIES; LEUKEMIA, PROMYELOCYTIC, ACUTE; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; NUCLEIC ACIDS; VIRAL PROTEINS;

EID: 79959553618     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3889     Document Type: Article

References (65)

1. R. Bernardi & P. P. Pandolfi: Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. 8, 1006-1016 (2007) (Pubitemid 350174636)
2. Van Damme E, K. Laukens, T. H. Dang and X. Van Ostade: A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics. Int. J. Biol. Sci. 6, 51-67 (2010)
3. L. A. Conlan, C. J. McNees and J. Heierhorst: Proteasome-dependent dispersal of PML nuclear bodies in response to alkylating DNA damage. Oncogene 23, 307-310 (2004) (Pubitemid 38142266)
4. K. Lijima, K. Komatsu, S. Matsuura and H. Tauchi: The Nijmegen breakage syndrome gene and its role in genome stability. Chromosoma 113, 53-61 (2004) (Pubitemid 39294901)
5. R. Bernardi, A. Papa and P. P. Pandolfi: Regulation of apoptosis by PML and the PML-NBs. Oncogene 27, 6299-6312 (2008)
6. E. Krieghoff-Henning & T. G. Hofmann: Role of nuclear bodies in apoptosis signalling. Biochim. Biophys. Acta 1783, 2185-2194 (2008)
7. R. D. Everett, W. C. Earnshaw, A. F. Pluta, T. Sternsdorf, A. M. Ainsztein, M. Carmena, S. Ruchaud, W. L. Hsu and A. Orr: A dynamic connection between centromeres and ND10 proteins. J. Cell Sci. 112 ( Pt 20), 3443-3454 (1999)
8. G. Ferbeyre: PML a target of translocations in APL is a regulator of cellular senescence. Leukemia 16, 1918-1926 (2002) (Pubitemid 35203434)
9. F. A. Mallette, S. Goumard, M. F. Gaumont-Leclerc, O. Moiseeva and G. Ferbeyre: Human fibroblasts require the Rb family of tumor suppressors, but not p53, for PMLinduced senescence. Oncogene 23, 91-99 (2004) (Pubitemid 38142243)
10. H. K. Lai & K. L. Borden: The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA. Oncogene 19, 1623-1634 (2000) (Pubitemid 30200964)
11. Y. Shima, T. Shima, T. Chiba, T. Irimura, P. P. Pandolfi and I. Kitabayashi: PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation. Mol. Cell Biol. 28, 7126-7138 (2008)
12. de The H., C. Lavau, A. Marchio, C. Chomienne, L. Degos and A. Dejean: The PML-RAR alpha fusion mRNA generated by the t (15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66, 675-684 (1991) (Pubitemid 121001703)
13. M. K. Chelbi-Alix, F. Quignon, L. Pelicano, M. H. Koken and T. H. de: Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J. Virol. 72, 1043-1051 (1998) (Pubitemid 28116883)
14. L. Espert, G. Degols, C. Gongora, D. Blondel, B. R. Williams, R. H. Silverman and N. Mechti: ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses. J. Biol. Chem. 278, 16151-16158 (2003) (Pubitemid 36799737)
15. Z. X. Xu, A. Timanova-Atanasova, R. X. Zhao and K. S. Chang: PML colocalizes with and stabilizes the DNA damage response protein TopBP1. Mol. Cell Biol. 23, 4247-4256 (2003) (Pubitemid 36666427)
16. T. Regad & M. K. Chelbi-Alix: Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene 20, 7274-7286 (2001) (Pubitemid 33105016)
17. D. Xu, M. Holko, A. J. Sadler, B. Scott, S. Higashiyama, W. Berkofsky-Fessler, M. J. McConnell, P. P. Pandolfi, J. D. Licht and B. R. Williams: Promyelocytic leukemia zinc finger protein regulates interferon-mediated innate immunity. Immunity. 30, 802-816 (2009)
18. K. C. Chang, E. Hansen, L. Foroni, J. Lida and G. Goldspink: Molecular and functional analysis of the virusand interferon-inducible human MxA promoter. Arch. Virol. 117, 1-15 (1991)
19. A. J. Rivett, S. Bose, P. Brooks and K. I. Broadfoot: Regulation of proteasome complexes by gamma-interferon and phosphorylation. Biochimie 83, 363-366 (2001) (Pubitemid 32293658)
20. H. H. Guldner, C. Szostecki, T. Grotzinger and H. Will: IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. J. Immunol. 149, 4067-4073 (1992) (Pubitemid 23068894)
21. M. K. Chelbi-Alix, L. Pelicano, F. Quignon, M. H. Koken, L. Venturini, M. Stadler, J. Pavlovic, L. Degos and T. H. de: Induction of the PML protein by interferons in normal and APL cells. Leukemia 9, 2027-2033 (1995) (Pubitemid 26023786)
22. C. Gongora, G. David, L. Pintard, C. Tissot, T. D. Hua, A. Dejean and N. Mechti: Molecular cloning of a new interferon-induced PML nuclear body-associated protein. J. Biol. Chem. 272, 19457-19463 (1997) (Pubitemid 27337744)
23. S. C. Van, R. Hagglund, P. Lopez and B. Roizman: The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity. Proc. Natl. Acad. Sci. U. S. A 98, 8815-8820 (2001) (Pubitemid 32678110)
24. C. Boutell, A. Orr and R. D. Everett: PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICP0. J. Virol. 77, 8686-8694 (2003) (Pubitemid 36936079)
25. M. K. Chelbi-Alix & T. H. de: Herpes virus induced proteasome-dependent degradation of the nuclear bodiesassociated PML and Sp100 proteins. Oncogene 18, 935-941 (1999) (Pubitemid 29086270)
26. S. Muller & A. Dejean: Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100proteins, correlating with nuclear body disruption. J. Virol. 73, 5137-5143 (1999) (Pubitemid 29246776)
27. Y. Xu, J. H. Ahn, M. Cheng, C. M. apRhys, C. J. Chiou, J. Zong, M. J. Matunis and G. S. Hayward: Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO- 1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression. J. Virol. 75, 10683-10695 (2001) (Pubitemid 33031538)
28. K. L. Borden, E. J. Campbell Dwyer and M. S. Salvato: An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J. Virol. 72, 758-766 (1998) (Pubitemid 28048896)
29. J. D. Evans & P. Hearing: Distinct roles of the Adenovirus E4 ORF3 protein in viral DNA replication and inhibition of genome concatenation. J. Virol. 77, 5295-5304 (2003) (Pubitemid 36460943)
30. L. Florin, F. Schafer, K. Sotlar, R. E. Streeck and M. Sapp: Reorganization of nuclear domain 10 induced by papillomavirus capsid protein l2. 295, 97-107 (2002)
31. A. M. Ishov, O. V. Vladimirova and G. G. Maul: Daxxmediated accumulation of human cytomegalovirus tegument protein pp71 at ND10 facilitates initiation of viral infection at these nuclear domains. J. Virol. 76, 7705-7712 (2002) (Pubitemid 34760994)
32. D. E. Wilkinson & S. K. Weller: Recruitment of cellular recombination and repair proteins to sites of herpes simplex virus type 1 DNA replication is dependent on the composition of viral proteins within prereplicative sites and correlates with the induction of the DNA damage response. J. Virol. 78, 4783-4796 (2004) (Pubitemid 38501099)
33. T. Shibata, T. Tanaka, K. Shimizu, S. Hayakawa and K. Kuroda: Immunofluorescence imaging of the influenza virus M1 protein is dependent on the fixation method. J. Virol. Methods 156, 162-165 (2009)
34. O. Bischof, K. Nacerddine and A. Dejean: Human papillomavirus oncoprotein E7 targets the promyelocytic leukemia protein and circumvents cellular senescence via the Rb and p53 tumor suppressor pathways. Mol. Cell Biol. 25, 1013-1024 (2005) (Pubitemid 40165809)
35. A. Moller & M. L. Schmitz: Viruses as hijackers of PML nuclear bodies. Arch. Immunol. Ther. Exp. (Warsz. ) 51, 295-300 (2003) (Pubitemid 37420327)
36. R. D. Everett: DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 20, 7266-7273 (2001) (Pubitemid 33105015)
37. P. Shannon, A. Markiel, O. Ozier, N. S. Baliga, J. T. Wang, D. Ramage, N. Amin, B. Schwikowski and T. Ideker: Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498-2504 (2003) (Pubitemid 37428274)
38. T. Regad, A. Saib, V. Lallemand-Breitenbach, P. P. Pandolfi, T. H. de and M. K. Chelbi-Alix: PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J. 20, 3495-3505 (2001) (Pubitemid 32634356)
39. M. Djavani, J. Rodas, I. S. Lukashevich, D. Horejsh, P. P. Pandolfi, K. L. Borden and M. S. Salvato: Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus. J. Virol. 75, 6204-6208 (2001) (Pubitemid 32553152)
40. V. Doucas, A. M. Ishov, A. Romo, H. Juguilon, M. D. Weitzman, R. M. Evans and G. G. Maul: Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev. 10, 196-207 (1996) (Pubitemid 26044607)
41. N. Tavalai, P. Papior, S. Rechter and T. Stamminger: Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J. Virol. 82, 126-137 (2008) (Pubitemid 350309130)
42. L. Florin, F. Schafer, K. Sotlar, R. E. Streeck and M. Sapp: Reorganization of nuclear domain 10 induced by papillomavirus capsid protein l2. 295, 97-107 (2002)
43. P. Bell, R. Brazas, D. Ganem and G. G. Maul: Hepatitis delta virus replication generates complexes of large hepatitis delta antigen and antigenomic RNA that affiliate with and alter nuclear domain 10. J. Virol. 74, 5329-5336 (2000) (Pubitemid 30313875)
44. G. G. Maul, A. M. Ishov and R. D. Everett: Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1. Virology 217, 67-75 (1996) (Pubitemid 26103599)
45. L. Florin, F. Schafer, K. Sotlar, R. E. Streeck and M. Sapp: Reorganization of nuclear domain 10 induced by papillomavirus capsid protein l2. Virology 295, 97-107 (2002)
46. J. Salsman, N. Zimmerman, T. Chen, M. Domagala and L. Frappier: Genome-wide screen of three herpesviruses for protein subcellular localization and alteration of PML nuclear bodies. PLoS. Pathog. 4, e1000100 (2008)
47. Y. L. Chung & T. Y. Tsai: Promyelocytic leukemia nuclear bodies link the DNA damage repair pathway with hepatitis B virus replication: implications for hepatitis B virus exacerbation during chemotherapy and radiotherapy. Mol. Cancer Res. 7, 1672-1685 (2009)
48. T. Nojima, T. Oshiro-Ideue, H. Nakanoya, H. Kawamura, T. Morimoto, Y. Kawaguchi, N. Kataoka and M. Hagiwara: Herpesvirus protein ICP27 switches PML isoform by altering mRNA splicing. Nucleic Acids Res. 37, 6515-6527 (2009)
49. A. J. Ullman & P. Hearing: Cellular proteins PML and Daxx mediate an innate antiviral defense antagonized by the adenovirus E4 ORF3 protein. J. Virol. 82, 7325-7335 (2008) (Pubitemid 352031201)
50. D. Baltimore: Expression of animal virus genomes. Bacteriol. Rev. 35, 235-241 (1971)
51. D. Blondel, T. Regad, N. Poisson, B. Pavie, F. Harper, P. P. Pandolfi, T. H. de and M. K. Chelbi-Alix: Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies. Oncogene 21, 7957-7970 (2002) (Pubitemid 35430607)
52. M. K. Chelbi-Alix, F. Quignon, L. Pelicano, M. H. Koken and T. H. de: Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J. Virol. 72, 1043-1051 (1998) (Pubitemid 28116883)
53. D. Blondel, S. Kheddache, X. Lahaye, L. Dianoux and M. K. Chelbi-Alix: Resistance to Rabies viral infection conferred by PMLIV isoform. J. Virol. (2010)
54. A. S. Bjorndal, L. Szekely and F. Elgh: Ebola virus infection inversely correlates with the overall expression levels of promyelocytic leukaemia (PML) protein in cultured cells. BMC. Microbiol. 3, 6 (2003)
55. A. R. Brasier, H. Spratt, Z. Wu, I. Boldogh, Y. Zhang, R. P. Garofalo, A. Casola, J. Pashmi, A. Haag, B. Luxon and A. Kurosky: Nuclear heat shock response and novel nuclear domain 10 reorganization in respiratory syncytial virus-infected a549 cells identified by high-resolution twodimensional gel electrophoresis. J. Virol. 78, 11461-11476 (2004) (Pubitemid 39390734)
56. M. Stremlau, M. Perron, S. Welikala and J. Sodroski: Species-specific variation in the B30.2 (SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction. J. Virol. 79, 3139-3145 (2005) (Pubitemid 40270592)
57. P. D. Uchil, B. D. Quinlan, W. T. Chan, J. M. Luna and W. Mothes: TRIM E3 ligases interfere with early and late stages of the retroviral life cycle. PLoS. Pathog. 4, e16 (2008)
58. P. Turelli, V. Doucas, E. Craig, B. Mangeat, N. Klages, R. Evans, G. Kalpana and D. Trono: Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. Mol. Cell 7, 1245-1254 (2001) (Pubitemid 32607358)
59. L. Berthoux, G. J. Towers, C. Gurer, P. Salomoni, P. P. Pandolfi and J. Luban: As (2)O (3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity. J. Virol. 77, 3167-3180 (2003) (Pubitemid 36228101)
60. P. Bell, L. J. Montaner and G. G. Maul: Accumulation and intranuclear distribution of unintegrated human immunodeficiency virus type 1 DNA. J. Virol. 75, 7683-7691 (2001) (Pubitemid 32738026)
61. R. Apweiler, A. Bairoch, C. H. Wu, W. C. Barker, B. Boeckmann, S. Ferro, E. Gasteiger, H. Huang, R. Lopez, M. Magrane, M. J. Martin, D. A. Natale, C. O'Donovan, N. Redaschi and L. S. Yeh: UniProt: the Universal Protein knowledgebase. Nucleic Acids Res. 32, D115-D119 (2004) (Pubitemid 38081617)
62. M. Ashburner, C. A. Ball, J. A. Blake, D. Botstein, H. Butler, J. M. Cherry, A. P. Davis, K. Dolinski, S. S. Dwight, J. T. Eppig, M. A. Harris, D. P. Hill, L. Issel- Tarver, A. Kasarskis, S. Lewis, J. C. Matese, J. E. Richardson, M. Ringwald, G. M. Rubin and G. Sherlock: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25-29 (2000) (Pubitemid 30257031)
63. E. B. Carstens: Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2009). Arch. Virol. 155, 133-146 (2010)
64. C. Stark, B. J. Breitkreutz, T. Reguly, L. Boucher, A. Breitkreutz and M. Tyers: BioGRID: a general repository for interaction datasets. Nucleic Acids Res. 34, D535-D539 (2006)
65. D. J. McGeoch, F. J. Rixon and A. J. Davison: Topics in herpesvirus genomics and evolution. Virus Res. 117, 90-104 (2006)